Limerston Capital portfolio company WMP Group appoints new CFO to support group expansion

Limerston Capital LLP (“Limerston Capital”) is pleased to announce that Limerston Capital Partners I, L.P. portfolio company WMP Group (“WMP” or the “Group”) has appointed a new CFO, Nick Graham, to help oversee its growth trajectory and bring together the different finance functions within the Group.


WMP Group is the UK’s leading provider of testing services to the medical devices industry. Its clients range from blue chip/top 10 device manufacturers to smaller innovators with teams of 100 or less. The Group consists of Wickham Micro and MET, who are at the forefront of microbiology and physical testing respectively. Wickham is the longest established micro lab in the UK, leading the industry for over 60 years, whilst MET has built its pre-eminent position in physical testing as well as chemical characterisation over the past 25 years. Between them their clients recognise their exceptional technical expertise, along with high service levels and support on crucial applications to respective regulators.


Nick Graham joins from PropFin, a property financing business, where he was Head of Finance. Nick also has significant experience across a number of different large corporates including John Lewis, Burtons Biscuits and British Airways, having started his career at KPMG in New Zealand.


Jane Grewar, Operating Partner of Limerston Capital, said, “This is the first of several Group level appointments following industry veteran Mark Hammond joining as CEO earlier in the year. As we work with management to progress our plans to expand WMP’s service offering in Europe and the US, we want to ensure there is a cohesive Group team, depth of capability and strategy.”


Mark Hammond, Group CEO, commented, “We are delighted to welcome Nick to the WMP team and he will join me in working across all divisions of the Group as we build a global platform providing unparalleled service levels in terms of technical quality, turnaround times and client service.”



For more information, please contact:

Martim Avillez, Limerston Capital Founding Partner

martim.avillez@limerstoncap.com +44 (0)203 897 1860


Media:

Caroline Villiers cvilliers@keplercomms.com +44 (0)7808 585184

Charlotte Balbirnie cbalbirnie@keplercomms.com +44 (0)7989 528421

About Limerston Capital

Founded in 2015 by James Paget, João Rosa and Martim Avillez, London based Limerston Capital pursues control investments in UK mid-market companies and seeks to create value through the firm’s buy-and-build and operationally focused model. The firm targets businesses with EBITDA of between £5 million and £15 million that have a solid value proposition, but have potential for operational improvements, have mispriced underlying returns on capital and provide opportunities for strategic repositioning via consolidation.

www.limerstoncap.com

About WMP Group

WMP Group provides testing services to the medical devices industry. The Group consists of Wickham Micro and MET, leaders in the UK in microbiology and physical testing respectively. Its clients range from blue chip/top 10 device manufacturers to smaller innovators with teams of 100 or less. Wickham, with its 60 years of heritage is the longest established micro lab in the UK, and MET has built its leading position in physical testing over the past 25 years.

About Limerston Capital

Limerston Capital is a private equity firm with over £300 million under management. We target UK businesses valued at £20 - £200 million, partnering with management teams to help build them into industry leaders. 

 

We differentiate by providing strong operational and acquisition support to our companies through our fully-integrated and dedicated operational and investment teams.